 Efficacy ibopamine treatment heart failure Loss myocardial contractility reflexly vasoconstriction neuroendocrine excitation pathophysiologic hallmarks low-output heart failure Drugs consequences considerable therapeutic potential consequences syndrome Ibopamine possesses potential unique ability dopaminergic- beta-adrenoreceptors heart circulatory system Stimulation dopaminergic- receptors results vasodilatation regional vascular territories agonist activity mild positive inotropic activity heart whereas stimulation presynaptic dopaminergic- receptors sympathetic neural outflow drug renin-angiotensin-aldosterone system addition direct natriuretic activity pharmacodynamic effects ibopamine metabolite epinine measurable therapeutic benefits patients chronic heart failure increase peripheral blood flow regional vascular territories kidneys increased cardiac output stroke volume reduction left ventricular pressure work wall stress myocardial oxygen consumption Plasma norepinephrine angiotensin aldosterone renal sodium excretion hemodynamic neuroendocrine activities subject tolerance sustained administration drug significant improvement symptoms exercise tolerance New York Heart Association classification disability important proarrhythmic effects sustained treatment minimal side effects long-term treatment enhance safety profile drug